Ability To Follow Drug Treatment With Calcium And Vitamin D In Postmenopausal Women With Reduced Bone Mass.

dc.creatorde Castro Gomes, Débora Alessandra
dc.creatorValadares, Ana Lúcia Ribeiro
dc.creatorPinto-Neto, Aarão Mendes
dc.creatorMorais, Sirlei Siani
dc.creatorCosta-Paiva, Lúcia
dc.date2012-Sep
dc.date2015-11-27T13:28:35Z
dc.date2015-11-27T13:28:35Z
dc.date.accessioned2018-03-29T01:15:29Z
dc.date.available2018-03-29T01:15:29Z
dc.identifierMenopause (new York, N.y.). v. 19, n. 9, p. 989-94, 2012-Sep.
dc.identifier1530-0374
dc.identifier10.1097/gme.0b013e318247e86a
dc.identifierhttp://www.ncbi.nlm.nih.gov/pubmed/22668820
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/200040
dc.identifier22668820
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1300273
dc.descriptionThe aim of this study was to evaluate the ability of women with reduced bone mass to follow calcium/vitamin D treatment in relation to prescribed regimen, dose, indication, mode of intake, and the associated factors. A cross-sectional study of postmenopausal women taking medication after bone mineral density diagnosis of osteopenia or osteoporosis was conducted using the MedTake questionnaire. A total of 186 patients attending a menopause clinic were studied. Sociodemographic characteristics, history of comorbid conditions, concomitant use of medication, length of medication use, and ability to follow treatment in relation to prescribed regimen, dose, indication, and mode of ingestion were assessed. The mean (SD) age of the women analyzed was 61.6 (8.21) years. The mean time since menopause was 16.8 years. Most women reported having difficulty reading, and 79% were white. The ability to follow treatment, evaluated using MedTake, was lower than 60% in most women. Taking the wrong dose was the most frequent error. The only factor associated with inadequate treatment was the use of concomitant medication (odds ratio, 2.32; 95% CI, 1.06-5.08). The ability to follow adjuvant calcium and vitamin D treatment for decreased bone mass is low and associated with concomitant use of medication.
dc.description19
dc.description989-94
dc.languageeng
dc.relationMenopause (new York, N.y.)
dc.relationMenopause
dc.rightsfechado
dc.rights
dc.sourcePubMed
dc.subjectAdult
dc.subjectAged
dc.subjectAged, 80 And Over
dc.subjectBone Density
dc.subjectCalcium
dc.subjectCalcium, Dietary
dc.subjectCross-sectional Studies
dc.subjectDietary Supplements
dc.subjectFemale
dc.subjectHumans
dc.subjectMiddle Aged
dc.subjectOsteoporosis, Postmenopausal
dc.subjectPatient Compliance
dc.subjectPostmenopause
dc.subjectVitamin D
dc.titleAbility To Follow Drug Treatment With Calcium And Vitamin D In Postmenopausal Women With Reduced Bone Mass.
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución